HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Implantable chemotherapy-loaded silk protein materials for neuroblastoma treatment.

Abstract
Neuroblastoma is the most common extracranial childhood solid tumor. Treatment of high risk tumors require intense multicycle chemotherapies, resulting in short- and long-term toxicities. Here, we present treatment of an orthotopic neuroblastoma mouse model, with silk fibroin materials loaded with vincristine, doxorubicin or the combination as a intratumoral, sustained release system. The materials, loaded with vincristine with or without doxorubicin, significantly decreased neuroblastoma tumor growth compared to materials loaded without drug or doxorubicin only as well as intravenous (IV) drug treatment. The intratumoral drug concentration was significantly higher with intratumoral delivery versus IV. Furthermore, intratumor delivery decreased the maximum plasma concentration compared to IV delivery, reducing systemic exposure and possibly reduing long-term side effects of chemotherapy exposure. Histopathologically, tumors with remission periods >25 days before recurrence transformed from a "small-round-blue cell" (SBRC) to predominantly "large cell" neuroblastoma (LCN) histopathology, a more aggressive tumor subtype with unfavorable clinical outcomes. These results show that intratumoral chemotherapy delivery may be a treatment strategy for pediatric neuroblastoma, potentially translatable to other focal tumors types. Furthermore, this treatment modality allows for a clinically relevant mouse model of tumor transformation that may be used for studying the phenotypical tumor recurrence and developing more effective treatment strategies for recurrent tumors.
AuthorsJeannine Coburn, Jamie Harris, Alexander D Zakharov, Jennifer Poirier, Naohiko Ikegaki, Andre Kajdacsy-Balla, Monika Pilichowska, Alexander V Lyubimov, Hiroyuki Shimada, David L Kaplan, Bill Chiu
JournalInternational journal of cancer (Int J Cancer) Vol. 140 Issue 3 Pg. 726-735 (Feb 01 2017) ISSN: 1097-0215 [Electronic] United States
PMID27770551 (Publication Type: Journal Article)
Copyright© 2016 UICC.
Chemical References
  • Antineoplastic Agents
  • Delayed-Action Preparations
  • Silk
  • Vincristine
  • Doxorubicin
  • Fibroins
Topics
  • Animals
  • Antineoplastic Agents (administration & dosage)
  • Cell Line, Tumor
  • Delayed-Action Preparations (administration & dosage)
  • Disease Models, Animal
  • Doxorubicin (administration & dosage)
  • Drug Delivery Systems (methods)
  • Fibroins (administration & dosage)
  • Mice
  • Neoplasm Recurrence, Local (drug therapy)
  • Neuroblastoma (drug therapy)
  • Silk (administration & dosage)
  • Vincristine (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: